U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06802952) titled 'RTMS for CHR Based on Personalized Targets Using Magnetoencephalography' on Jan. 26.
Brief Summary: This study is an before-after study in the same subject, which enrolled 26 individuals with high-risk psychiatric syndrome (CHR). The target of subjects intervention relies on the results of magnetoencephalography localization. The medication and dosage remain unchanged during the intervention period or not yet taking antipsychotic medication. We assume that the intervention targets for each CHR subject are individualized.
Study Start Date: Feb. 10
Study Type: INTERVENTIONAL
Condition:
Clinical High-risk Syndrome of Psychosis
Inte...